News CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be The CanCertainty Coalition, a collaboration of 35 cancer patient groups, physicians and national healthcare charities…adminMay 7, 2015
News pERC Initial Recommendations Issued for Romidepsin (Istodax) On April 30, 2015, the pCODR Expert Review Committee (pERC) issued initial recommendations for Romidepsin…adminMay 1, 2015
News Health Canada approves Zydelig in CLL and Follicular lymphomas Health Canada approves ZYDELIG™ (idelalisib) for treatment of relapsed chronic lymphocyctic leukemia and conditionally approves…adminApril 28, 2015
News CLL patients with idelalisib (Zydelig) experience Lymphoma Canada is conducting a survey of CLL patients with experience with idelalisib (Zydelig) to…adminMarch 16, 2015
News Research Fellowship Applications Now Being Accepted Applications are now being accepted for the Lymphoma Canada Research Fellowship award. (more…)adminFebruary 18, 2015
News Patients with Romidepsin (Istodax) Experience – We Need Your Help! Lymphoma Canada is conducting a survey and interviews of lymphoma patients with experience with romidepsin…adminNovember 10, 2014
News Thank You for Participating in our Surveys Lymphoma Canada wishes to thank all of those who particpated in our recent surveys for…adminAugust 25, 2014
News June 7, 2014 Toronto Education Forum webcast is now archived Were you unable to attend our Toronto or Waterloo event on exciting new lymphoma and…adminJuly 29, 2014
News CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be There is no disputing a cancer diagnosis is among the worst news a person or…adminMarch 12, 2014
News Passion + Dedication= 2013 Lymphoma Canada Interns As a non-profit organization the Lymphoma Canada team set out to assist in preparing students…adminFebruary 18, 2014